Effect of Prophylactic TKI Therapy Post-transplants on Ph+ ALL Undergoing Allo-HSCT With MRD Positive Pre-transplants

Clinical trial NCT03624530 · UNKNOWN

Trial details

NCT number: NCT03624530
Sponsor: Nanfang Hospital, Southern Medical University
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Philadelphia Chromosome Positive Acute Lymphocytic Leukemia Tyrosine Kinase Inhibitor Minimal Residual Disease Allogeneic Hematopoietic Stem Cell Transplantation

Start date: 2018-08-01
Primary completion: 2021-07-01
Enrollment: 82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.